In the present study, it has been demonstrated that the treatment of hinokitiol in MCAO-induced embolic rats significantly reduced the expression of HIF-1α and iNOS, harmful to the postischemic brain, and may be of worth in the treatment of cerebral ischemia. This evidence concerns the gene HIF1A and Cerebral ischemia.